Royal College of Physicians of Edinburgh Consensus Conference on lipid lowering to prevent vascular events 17 & 18 March 1999.
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000191:economics / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D048909:Diabetes Complications; D004032:Diet; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011322:Primary Prevention; D012307:Risk Factors; D012606:Scotland; D016540:Smoking Cessation
D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D002784:Cholesterol; D001241:Aspirin